Prior Cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty

International Journal of Cardiology

Volumn 73, Issue 2, 2000, Pages 165-171

  Carlsson, Joerg ^a   Miketic, Sinisa ^b   Brom, Joachim ^c   Ross, Rolf ^c   Bachmann, Helmut ^c   Tebbe, Ulrich ^b  

^a KERCKHOFF HEART CENTER   (Germany)

^b KLINIKUM LIPPE DETMOLD   (Germany)

^c NOVARTIS PHARMA GMBH   (Germany)

Author keywords

Angioplasty; Chlamydia pneumoniae; Cytomegalovirus; Helicobacter pylori; Restenosis

Indexed keywords

ANGIOGRAPHY; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RESTENOSIS; RISK FACTOR; SERODIAGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CONSTRICTION, PATHOLOGIC; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; SEROLOGIC TESTS;

EID: 0034725062     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(00)00216-3     Document Type: Article

References (25)

1. Libby P., Egan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation. 96:1997;4095-4103.
2. Muhlestein J.B., Hammond E.H., Carlquist J.F., et al. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J. Am. Coll. Cardiol. 27:1996;1555-1561.
3. Saikku P., Leinonen M., Tenkanen L., et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann. Int. Med. 116:1992;273-278.
4. Miettinen H., Lehto S., Saikku P., et al. Association of Chlamydia pneumoniae and acute coronary heart events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur. Heart J. 17:1996;682-688.
5. Zhou Y.F., Leon M.B., Waclawiw M.A., et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:1996;624-630.
6. Torgano G., Cosentini R., Mandelli C., et al. Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma levels in patients with ischemic heart disease. Circulation. 99:1999;1555-1559.
7. Buffon A., Liuzzo G.M., Caligiuri G., et al. Association between prior Helicobacter pylori infection and the risk of restenosis after coronary angioplasty. Circulation. 96:1997;I-650. Suppl. I.
8. von Essen R., Ostermaier R., Grube E., et al. Effects of octreotide treatment on restenosis after coronary angioplasty. Results of the VERAS Study. Circulation. 96:1997;1482-1487.
9. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
10. Gurfinkel E., Bozovich G., Daroca A., Beck E., Mautner B. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 350:1997;404-407.
11. Gurfinkel E., Bozovich G., Beck E., et al. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS study. Eur. Heart J. 20:1999;121-127.
12. Gupta S., Leatham E.W., Carrington D., Mendall M.A., Kaski J.C., Camm A.J. Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation. 96:1997;404-407.
13. McDonagh T.A., Woodward M., Morrison C.E., et al. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur. Heart J. 18:1997;1257-1260.
14. Koenig W., Rothenbacher D., Hoffmeister A., et al. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease. Lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response. Circulation. 100:1999;2326-2331.
15. Anderson J.L., Muhlestein J.B., Carlquist J., et al. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The azithromycin in coronary artery disease: elimination of myocardial infection with Chlamydia (ACADEMIC) study. Circulation. 99:1999;1540-1547.
16. Muhlestein J.B., Carlquist J.F., Horne B.D., et al. No association between prior cytomegalovirus infection and the risk of clinical restenosis after percutaneous coronary interventions. Circulation. 96:1997;I-650. Suppl. I.
17. Thomas W., Lele S., Adler S., Goudreau E., Cowley M., Vetrovec G. Lack of evidence for a relationship between cytomegalovirus status in coronary angiographic restenosis. Circulation. 96:1997;I-650. Suppl. I.
18. Tiran A., Tio R., Oostenfeld E., et al. Serological response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty. Circulation. 94:1996;I-711. Suppl. I.
19. Blum A., Giladi M., Weinberg M., et al. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am. J. Cardiol. 81:1998;866-868.
20. Manegold C., Alwazzeh M., Jablonowski H., et al. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation. 99:1999;1290-1294.
21. Epstein S.E., Zhu J. Lack of association of infectious agents with risk of future myocardial infarction and stroke. Definitive evidence disproving the infection/coronary artery disease hypothesis? Circulation. 100:1999;1366-1368.
22. Chiu B., Viira E., Tucker W., et al. Chlamydia pneumoniae, cytomegalovirus and Herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 96:1997;2144-2148.
23. Bertrand M.E., Bauters C. Cytomegalovirus infection and coronary restenosis. Circulation. 99:1999;1278-1279.
24. Maass M., Gieffers J. Prominent serological response to Chlamydia pneumoniae in cardiovascular disease. Immunol. Infect. Dis. 6:1996;65-70.
25. Anderson H.V., Vignale S.J., Benedict C.R., Willerson J.T. Restenosis after coronary angioplasty. J. Interv. Cardiol. 6:1993;187-202.